Despite reduction in prices of several medicines by NPPA, quality problems with US FDA, competition and slowdown in approvals, 50 top Indian pharmaceutical companies registered satisfactory growth in net sales and earnings before depreciation, ... PharmaBiz, 4 days ago
Sales decline 31.92% to Rs 159.96 crore Net Loss of Ind-Swift Laboratories reported to Rs 18.77 crore in the quarter ended September 2014 as against net loss of Rs 8.57 crore during the previous quarter ended September 2013. Sales declined 31.92% to Rs 159.96 ...Business Standard, 2 weeks ago Ind-Swift Laboratories: Outcome of board meeting Money Control, 3 weeks ago Ind-Swift Laboratories: Updates on outcome of AGM Money Control, 4 weeks ago Ind-Swift Laboratories to hold board meeting Business Standard, 1 month ago
This page uses frames, but your browser doesn'tCapital Market, 3 weeks ago
"Worry does not empty tomorrow of its sorrow, it empties today of its strength." -Corrie Boom We are at the end of yet another truncated week which is set to see indices hitting a new high in early trade. On Thursday European Central Bank President ...India Infoline, 3 weeks ago
Excelsior Correspondent SAMBA, Oct 15: General Manager, District Industries Centre, Samba Satish Sharma, along with the District Officer, Pollution Control Board, Anil Sharma, today conducted surprise inspection of industrial units in Samba ...Daily Excelsior.com, 1 month ago
Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today. We have Piramal Enterprises, Rain Industries, Mirza International, Ashapura, Ind-Swift Laboratories, Venus Remedies, Yes Bank, Eros International, Indian Oil Corporation (IOC) ...Money Control, 2 months ago
on your WebpageAdd Widget >Get your members hooked!